Our Portfolio

Deerfield portfolio companies strive to advance healthcare in meaningful and innovative ways.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Industry
Clear
Purpose of Financing
Clear
Stage
Clear
Structure of Financing
Clear
Status of Investment
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
:
Tag
Showing 0 of 100
TriNetX
TriNetX
Healthcare Services
Jul 2015
Venture
Early Stage
Equity
Current
The Oncology Institute
The Oncology Institute
Healthcare Services
Feb 2020
Special Situations
Seed/Startup
Equity
Current
The Discovery Labs
The Discovery Labs
Healthcare Services
Oct 2020
Growth
Early Stage
Debt and Equity
Current
Telix
Telix
Therapeutics
Apr 2024
Current
Singular Genomics Systems
Singular Genomics Systems
Medical Technologies
Jun 2019
Venture
Mid Stage
Equity
Current
Synthekine
Synthekine
Therapeutics
Jun 2021
Growth
Early Stage
Equity
Current
Stellar Health
Stellar Health
Healthcare Services
Apr 2022
Growth
Mid Stage
Equity
Current
SpectraWAVE
SpectraWAVE
Medical Technologies
Apr 2018
Venture
Seed/Startup
Equity
Current
Stelexis Therapeutics
Stelexis Therapeutics
Therapeutics
Nov 2017
Venture
Seed/Startup
Debt and Equity
Current
Somatus
Somatus
Healthcare Services
May 2020
Growth
Mid Stage
Equity
Current
SHINE Technologies
SHINE Technologies
Medical Technologies
Nov 2018
Venture
Early Stage
Debt and Equity
Current
Reprieve Cardiovascular
Reprieve Cardiovascular
Medical Technologies
Jul 2020
Venture
Early Stage
Equity
Current
Recovery Centers of America
Recovery Centers of America
Healthcare Services
May 2015
Growth
Early Stage
Debt and Equity
Current
Relation Therapeutics
Relation Therapeutics
Therapeutics
Mar 2024
Venture
Early Stage
Equity
Current
Ray Therapeutics
Ray Therapeutics
Therapeutics
May 2023
Venture
Mid Stage
Equity
Current
DISCLAIMER

The portfolio companies shown represents a significant portion of the current portfolio of Deerfield funds utilizing the Private Design Strategy or Healthcare Innovations Strategy.  Exclusions include historical investments, research projects and related entities, companies in stealth mode, companies without material operations, companies in which Deerfield funds hold residual interests, investments in other funds, and investment portfolios of other Deerfield strategies. The specific portfolio companies identified are not representative of all of the portfolio companies purchased, sold, or recommended for Deerfield funds, and it should not be assumed that any investment in an identified portfolio company was or will be profitable. Actual holdings will vary for each Deerfield fund and there is no guarantee that a particular Deerfield fund will hold any or all of the portfolio companies listed.